论文部分内容阅读
Background & aim ErbB3 is upregulated in pancreatic cancer and has been associated with tumor progression, but little is known about regulatory mechanisms.In this study, we hypothesized that ErbB3 is a target of miR-148a and vertified the hypothesis through molecular methods.